JWK007 / Genevector Biotech - LARVOL DELTA

A Clinical Study Evaluating the Safety, Tolerability, and Initial Efficacy of Single Intravenous Infusion of JWK007 in Patients With Duchenne Muscular Dystrophy (DMD) (clinicaltrials.gov) - P1 | N=3 | Active, not recruiting | Sponsor: West China Hospital | Recruiting ➔ Active, not recruiting | Trial completion date: Dec 2028 ➔ Nov 2029 | Trial primary completion date: Jun 2025 ➔ Nov 2029

Enrollment closed • Trial completion date • Trial primary completion date • Duchenne Muscular Dystrophy • Genetic Disorders • Muscular Dystrophy